Irish SME VC Funding Falls 58% to €221.7 Million in Q1 as Mid-Size Deals Slump
Updated
Updated · RTÉ News · May 25
Irish SME VC Funding Falls 58% to €221.7 Million in Q1 as Mid-Size Deals Slump
1 articles · Updated · RTÉ News · May 25
€221.7 million in venture funding went to Irish SMEs in the first quarter, down 58% from a record-strong period a year earlier, in what the Irish Venture Capital Association called a warning sign.
Mid-size rounds weakened sharply: deals worth €5 million to €10 million fell 62%, while €3 million to €5 million deals dropped 77%, underscoring strain in a market heavily exposed to overseas capital.
Life sciences accounted for more than half of all funding, while fintech took 13% and software 12%; Neurent Medical raised the largest round at €62.5 million, followed by Aerska at €33 million.
Ireland's mix contrasts with a global VC market dominated by pure-play AI, with Irish companies more often embedding AI across sectors than raising large standalone AI rounds.
The IVCA said stronger domestic capital remains critical despite recent policy support, including higher Enterprise Ireland investment and the government's €250 million seed and venture scheme, especially as multinational job losses begin to emerge.
As foreign VCs pull back, can Ireland's domestic market bridge a €1.3 billion gap to save its most promising tech firms?
Amid a global AI gold rush, why is Ireland’s innovative tech sector being left behind in the venture capital cold?
Irish Venture Capital Falls 58% in Q1 2026: Global Shocks Expose Need for Homegrown Investment
Overview
Irish venture capital funding for SMEs saw a sharp decline in Q1 2026, with total investment dropping to €221.7 million from €532 million the previous year. The number of deals also fell by 20%, and mid-size investments between €3 million and €10 million experienced reductions of up to 77%. However, smaller investments under €1 million remained stable, showing ongoing support for early-stage startups. This downturn highlights a shift in investor appetite, with larger growth-stage funding becoming harder to secure, while early-stage ventures continue to attract interest despite the challenging environment.